NIH Launches Human RSV Study
Understanding Infection in Healthy Adults to Aid Development of RSV Medicines, Vaccines
A new study will expose healthy adult volunteers to respiratory syncytial virus (RSV), a virus that causes cold-like symptoms in adults. Better understanding of how adults develop RSV infection and immune system responses to infection will assist researchers in developing and testing future antivirals and vaccines to combat the virus. The research is being conducted by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.
This page was last updated on Friday, January 21, 2022